Targeting oncogenic transcriptional programs in Juvenile Myelomonocytic Leukemia
Targeting oncogenic transcriptional programs in Juvenile Myelomonocytic Leukemia
Dr. Julia Maxson, Ph.D. – Oregon Health & Science University – OHSU, Portland, OR
Modeling relapsed hypodiploid B-cell acute lymphoblastic leukemia using humanized in vivo systems
Modeling relapsed hypodiploid B-cell acute lymphoblastic leukemia using humanized in vivo systems
Dr. Matthew Witkowski – University of Colorado Denver, AMC and DC
Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Role of PAX5 mutations in B-cell acute lymphoblastic leukemia
Dr. Zhaohui Gu – Beckman Research Institute of the City of Hope, Duarte, CA
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Activating type I interferon-driven immune surveillance to treat pediatric B-cell acute lymphoblastic leukemia
Beckman Research Institute of the City of Hope, Duarte, CA
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
PTEFb-dependent transcriptional reorganization in the glioma adaptive response to radiotherapy
University of Colorado Denver, AMC and DC, Aurora, CO
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
Stimulating Macrophages to Eat Pediatric Brain Cancer: Combining Anti-CD47 and Irradiation to Enhance the Treatment of Group 3 Medulloblastoma
University of Utah, Salt Lake City, UT
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Overcoming Resistance of CAR T Cells Immunotherapy with CBP/ß-catenin Antagonists in Pediatric Glioma and Ependymoma
Beckman Research Institute of the City of Hope, Duarte, CA
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Development of anti-KIT antibodies and immunotoxins as therapeutics and HSCT conditioning agents for pediatric acute myeloid leukemia
Stanford University, Stanford, CA
Artificial Intelligence for Pediatric Cancer
Artificial Intelligence for Pediatric Cancer
Stanford University, Palo Alto, CA
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
Overcoming Innate Immune Evasion in Pediatric High Grade Glioma
University of Colorado Denver, AMC and DC, Aurora, CO
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Predicting Post-Treatment Relapse in Pediatric AML Using Single-Cell Proteomics
Stanford University, Stanford, CA
Epigenetic Drivers in Rhabdomyosarcoma
Epigenetic Drivers in Rhabdomyosarcoma
University of Washington, Seattle, WA
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
Improving Brain Tumor Targeted Antigen Receptor T Cell Function
City of Hope, Duarte, CA
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
In-Vivo Organogenesis Approach to Elucidate Drivers of Medulloblastoma Development and Identify Therapeutic Targets
University of California, San Francisco, CA
Pediatric ALL CAR T-Cell Therapy
Pediatric ALL CAR T-Cell Therapy
Seattle Children’s Hospital, Seattle, WA
